Download PDF
J Neurol Surg A Cent Eur Neurosurg 2016; 77(02): 139-143
DOI: 10.1055/s-0035-1558413
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo

Alessandro Landi
1   Department of Neurosurgery, Sapienza University of Rome, Rome, Italy
,
Fabrizio Gregori
1   Department of Neurosurgery, Sapienza University of Rome, Rome, Italy
,
Nicola Marotta
1   Department of Neurosurgery, Sapienza University of Rome, Rome, Italy
,
Roberto Delfini
1   Department of Neurosurgery, Sapienza University of Rome, Rome, Italy
› Author Affiliations
Further Information

Publication History

08 July 2014

24 April 2015

Publication Date:
09 September 2015 (online)

Also available at
    Permissions and Reprints

See also:

Commentary on: Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal vs SurgifloJ Neurol Surg A Cent Eur Neurosurg 2016; 77(02): 143-145
DOI: 10.1055/s-0035-1566113

Abstract

Introduction Accurate hemostasis in surgical practice is critical. The need for optimal atraumatic hemostasis has become compelling in neurosurgery. A simple and safe gelified hemostatic matrix is often used. This prospective study evaluates two different hemostatics, FloSeal (Baxter Healthcare, Deerfield, Illinois, United States) and Surgiflo (Ethicon, Somerville, New Jersey, United States), for bleeding control during spine surgery, considering their efficacy, safety, and ease of use.

Materials and Methods From January 2012 to December 2013, we recruited 149 patients. Inclusion criteria were age between 25 and 80 years, diagnosis of degenerative or traumatic pathology of the lumbar or thoracolumbar spine, and persistent bleeding not responding to standard hemostatic techniques. All patients underwent laminectomy or laminoarthrectomy, with exposure of the perivertebral venous plexus. Our aim was to stop the bleeding completely in the operative field by application of hemostatic gel. All patients were evaluated during the follow-up period with a clinical and neurologic examination. All patients underwent a computed tomography scan 3 months after the intervention.

Results We included 149 patients in our study: 98 men and 51 women. Overall, 92 patients were affected by a degenerative condition and 57 by traumatic pathology. A total of 42 patients had anticoagulant and/or antiaggregant therapy preoperatively. In all cases, massive bleeding originated from the epidural venous plexus. FloSeal was used in 86 cases and Surgiflo in 63. A complete hemostasis was achieved in all patients within 3 minutes, 30 seconds and 7 minutes (FloSeal, 5 minutes, 35 seconds ± 52 seconds; Surgiflo, 5 minutes, 32 seconds ± 54 seconds). Statistical analysis did not show any association between coagulation time and hemostatics, age, sex, and the pathology treated. Previous therapy with antiaggregants and/or anticoagulants determined a slight increase in the time of hemostasis without any statistical differences. The clinical and radiological follow-up showed no evidence of postsurgical hematomas.

Conclusions Comparative analysis of the two products did not show any relevant differences in terms of efficacy and ease of use or their effectiveness in bleeding control. Their use was valid even in patients who used antiaggregant/anticoagulant drugs preoperatively. Both FloSeal and Surgiflo can be considered good choices for controlling bleeding in spinal surgery.

Keywords

spinal hemostasis - hemostatic gel matrix - Surgiflo - FloSeal - thoracolumbar spine surgery
 

  • References

  • 1 Gabay M, Boucher BA. An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. Pharmacotherapy 2013; 33 (9) 935-955
    CrossrefPubMedGoogle Scholar
  • 2 Cappabianca P, Esposito F, Esposito I, Cavallo LM, Leone CA. Use of a thrombin-gelatin haemostatic matrix in endoscopic endonasal extended approaches: technical note. Acta Neurochir (Wien) 2009; 151 (1) 69-77 ; discussion 77
    CrossrefPubMedGoogle Scholar
  • 3 Chodkiewicz JP. Methods of hemostasis in neurosurgery: contact processes [in French]. Neurochirurgie 1973; 19 (3) 244-250
    PubMedGoogle Scholar
  • 4 Gerald AG. Update on hemostasis: neurosurgery. Surgery 2007; 142 (4, Suppl): S55-S60
    CrossrefPubMedGoogle Scholar
  • 5 Gazzeri R, Galarza M, Neroni M, Alfieri A, Giordano M. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study. Acta Neurochir (Wien) 2011; 153 (1) 148-154 ; discussion 155
    CrossrefPubMedGoogle Scholar
  • 6 Angioli R, Muzii L, Montera R , et al. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma. J Minim Invasive Gynecol 2009; 16 (2) 153-156
    CrossrefPubMedGoogle Scholar
  • 7 Buiret G, Pavic M, Pignat JC, Pasquet F. Gelatin-thrombin matrix: a new and simple way to manage recurrent epistaxis in hematology units. Case Rep Otolaryngol 2013; 2013: 851270
    PubMedGoogle Scholar
  • 8 Dhillon S. Fibrin sealant (evicel® [quixil®/crosseal™]): a review of its use as supportive treatment for haemostasis in surgery. Drugs 2011; 71 (14) 1893-1915
    CrossrefPubMedGoogle Scholar
  • 9 Di Francesco A, Flamini S, Fiori F, Mastri F. Hemostatic matrix effects on blood loss after total knee arthroplasty: a randomized controlled trial. Indian J Orthop 2013; 47 (5) 474-481
    CrossrefPubMedGoogle Scholar
  • 10 Dyer SR, Bathula S, Durvasula P , et al. Intraoperative use of FloSeal with adenotonsillectomy to prevent adverse postoperative outcomes in pediatric patients. Otolaryngol Head Neck Surg 2013; 149 (2) 312-317
    CrossrefPubMedGoogle Scholar
  • 11 Jain V, Gupta A, Gulia A , et al. Gelatin-thrombin hemostatic matrix injection to salvage refractory post-renal graft biopsy bleed. Indian J Nephrol 2013; 23 (2) 149-152
    CrossrefPubMedGoogle Scholar
  • 12 Lewis KM, Atlee HD, Mannone AJ , et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg 2013; 26 (3) 141-148
    CrossrefPubMedGoogle Scholar
  • 13 Mayol JM, Zapata C. Gelatin-thrombin matrix for intraoperative hemostasis in abdomino-pelvic surgery: a systematic review. Surg Technol Int 2013; 23: 23-28
    PubMedGoogle Scholar
  • 14 Oz MC, Rondinone JF, Shargill NS. FloSeal Matrix: new generation topical hemostatic sealant. J Card Surg 2003; 18 (6) 486-493
    CrossrefPubMedGoogle Scholar
  • 15 Palacios DA, McDonald M, Miyake M, Rosser CJ. Pilot study comparing the two hemostatic agents in patients undergoing partial nephrectomy. BMC Res Notes 2013; 6: 399
    CrossrefPubMedGoogle Scholar
  • 16 Slaba S, Braidy C, Sader RB, Hokayem N, Nassar J. Giant venous malformation of the tongue: the value of Surgiflo [in French]. J Mal Vasc 2010; 35 (3) 197-201 [Article in French]
    CrossrefPubMedGoogle Scholar
  • 17 Testini M, Marzaioli R, Lissidini G , et al. The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg 2009; 394 (5) 837-842
    CrossrefPubMedGoogle Scholar
  • 18 Wohlmuth CT, Dela Merced J. Gelatin-thrombin hemostatic matrix in the management of placental site postpartum hemorrhage: a case report. J Reprod Med 2011; 56 (5–6) 271-273
    PubMedGoogle Scholar
  • 19 Clapp B, Santillan A. Small bowel obstruction after FloSeal use. JSLS 2011; 15 (3) 361-364
    CrossrefPubMedGoogle Scholar
  • 20 Gu X, Yang L, Wang S , et al. A rat model of radicular pain induced by chronic compression of lumbar dorsal root ganglion with SURGIFLO. Anesthesiology 2008; 108 (1) 113-121
    CrossrefPubMedGoogle Scholar
  • 21 Spencer HT, Hsu JT, McDonald DR, Karlin LI. Intraoperative anaphylaxis to gelatin in topical hemostatic agents during anterior spinal fusion: a case report. Spine J 2012; 12 (8) e1-e6
    PubMedGoogle Scholar
  • 22 Arand AG, Sawaya R. Intraoperative chemical hemostasis in neurosurgery. Neurosurgery 1986; 18 (2) 223-233
    CrossrefPubMedGoogle Scholar
  • 23 Benedetto N, Vannozzi R. Clip assisted use of gelatin-thrombin matrix sealant as a rescue procedure to treat a hidden arterial tear. Br J Neurosurg 2012; 26 (4) 568-569
    CrossrefPubMedGoogle Scholar
  • 24 Cho SK, Yi JS, Park MS , et al. Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. J Bone Joint Surg Am 2012; 94 (21) 1952-1958
    CrossrefPubMedGoogle Scholar
  • 25 Ellegala DB, Maartens NF, Laws Jr ER. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 2002; 51 (2) 513-515; discussion 515–516
    PubMedGoogle Scholar
  • 26 Fiss I, Danne M, Stendel R. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery. Neurol Med Chir (Tokyo) 2007; 47 (10) 462-467
    PubMedGoogle Scholar
  • 27 Gazzeri R, Galarza M, Neroni M, Alfieri A, Esposito S. Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage. J Neurosurg 2009; 110 (5) 939-942
    CrossrefPubMedGoogle Scholar
  • 28 Reeves A, Muhonen M, Loudon W. FloSeal hemostatic matrix use for intraventricular hemorrhage during a neuroendoscopic procedure. Minim Invasive Neurosurg 2011; 54 (3) 132-134
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Ujam A, Awad Z, Wong G, Tatla T, Farrell R. Safety trial of Floseal(®) haemostatic agent in head and neck surgery. Ann R Coll Surg Engl 2012; 94 (5) 336-339
    CrossrefPubMedGoogle Scholar
  • 30 Yao HH, Hong MK, Drummond KJ. Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant?. J Clin Neurosci 2013; 20 (3) 349-356
    CrossrefPubMedGoogle Scholar
  • 31 Gazzeri R, Galarza M, Alfier A. Safety biocompatibility of gelatin hemostatic matrix (FloSeal and Surgiflo) in neurosurgical procedures. Surg Technol Int 2012; 22: 49-54
    PubMedGoogle Scholar
  • 32 Gazzeri R, De Bonis C, Galarza M. Use of a thrombin-gelatin hemostatic matrix (Surgiflo) in spinal surgery. Surg Technol Int 2014; 25: 280-285
    PubMedGoogle Scholar
  • 33 Dogulu F, Durdag E, Cemil B, Kurt G, Ozgun G. The role of FloSeal in reducing epidural fibrosis in a rat laminectomy model. Neurol Neurochir Pol 2009; 43 (4) 346-351
    PubMedGoogle Scholar
  • 34 FloSeal Hemostatic Matrix instructions for use, Baxter (2014)
    PubMed
  • 35 Surgiflo Hemostatic Matrix kit, technical report, Ethicon (2012)
    PubMed